A precision agriculture solution using compact electron accelerators and AI-guided beam steering to deliver targeted irradiation to weeds without harming nearby crops. Offers a non-chemical weed control method that avoids herbicide resistance, leaves no residues, and is compatible with existing see-and-spray robotics.
This solution applies compact electron accelerator technology originally developed for radiation oncology to precision agriculture, specifically for postemergence weed control. By combining AI-driven weed identification with magnetic beam steering—similar to radiotherapy scanning techniques—the system delivers lethal megavoltage irradiation directly to weeds while keeping scatter dose to crops below growth-inhibition thresholds.
The approach addresses several critical challenges in modern agriculture. Herbicide resistance is a growing problem across major row crops, and this method provides a completely different mechanism of action that does not contribute to resistance development. Unlike chemical herbicides, irradiation leaves no environmental residue and may offer a more sustainable alternative for integrated weed management programs.
Target crops include corn, soybean, and sweet potato. Target weed species include yellow nutsedge, Palmer amaranth, entireleaf morningglory, sicklepod, and pink purslane—all major pests in southeastern U.S. cropping systems.
System components:
Performance estimates:
Validation design:
The concept is at an early-to-mid stage of development. Preliminary validation has demonstrated effective control of yellow nutsedge tubers at doses that are feasible for a mobile compact accelerator. Future greenhouse trials at NCSU and Duke will quantify crop tolerance and weed efficacy across multiple species and growth stages, while Monte Carlo simulations will characterize scatter dose for the proposed compact accelerator geometry. Additional engineering work is needed to integrate AI-guided targeting, magnetic steering, and accelerator mobility into a field-deployable platform.
Duke University is a mid-sized, comprehensive private research university in Durham, North Carolina, anchored by a globally recognized academic medical center. Co-located campus and clinical facilities enable rapid bench-to-bedside translation, and shared core laboratories are accessible to external partners. Proximity to Research Triangle Park links Duke to a dense network of R&D-intensive companies, supported by centralized corporate engagement for sponsored research and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD. A dedicated technology transfer office supports IP strategy, licensing, startups, and industry collaboration.